581 Boston Mills Road
Suite 300
Hudson, OH 44236
United States
440 666 7999
Sektor(en): Consumer Defensive
Branche: Packaged Foods
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Shuang Liu | Chairman, CEO & President | N/A | N/A | 1964 |
Ms. Hua Xie | Secretary, Principal Financial Officer, Principal Accounting Officer & Director | N/A | N/A | 1970 |
Mr. Li Yang | Treasurer & Director | N/A | N/A | 1969 |
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAIbovine cardiac vascular active peptide; Double Proline AG 3D active collagen peptide; cartilage peptide, a type II collagen peptide; Se Plus tablets and sugar master tablets. The company was incorporated in 2019 and is based in Hudson, Ohio.
Goldenwell Biotech, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.